ATE397069T1 - Basb205 polypeptide und dafür kodierende polynukleotide - Google Patents

Basb205 polypeptide und dafür kodierende polynukleotide

Info

Publication number
ATE397069T1
ATE397069T1 AT01976280T AT01976280T ATE397069T1 AT E397069 T1 ATE397069 T1 AT E397069T1 AT 01976280 T AT01976280 T AT 01976280T AT 01976280 T AT01976280 T AT 01976280T AT E397069 T1 ATE397069 T1 AT E397069T1
Authority
AT
Austria
Prior art keywords
polypeptides
coding therefor
polynucleotides coding
basb205
basb205 polypeptides
Prior art date
Application number
AT01976280T
Other languages
English (en)
Inventor
Joelle Thonnard
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE397069T1 publication Critical patent/ATE397069T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01976280T 2000-10-13 2001-10-05 Basb205 polypeptide und dafür kodierende polynukleotide ATE397069T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0025171.0A GB0025171D0 (en) 2000-10-13 2000-10-13 Novel compounds

Publications (1)

Publication Number Publication Date
ATE397069T1 true ATE397069T1 (de) 2008-06-15

Family

ID=9901255

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976280T ATE397069T1 (de) 2000-10-13 2001-10-05 Basb205 polypeptide und dafür kodierende polynukleotide

Country Status (12)

Country Link
US (2) US7838003B2 (de)
EP (2) EP1847609A1 (de)
AT (1) ATE397069T1 (de)
AU (1) AU2001295599A1 (de)
CA (1) CA2424938A1 (de)
CY (1) CY1108280T1 (de)
DE (1) DE60134253D1 (de)
DK (1) DK1326982T3 (de)
ES (1) ES2305111T3 (de)
GB (1) GB0025171D0 (de)
PT (1) PT1326982E (de)
WO (1) WO2002030971A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
US20150079132A1 (en) * 2013-09-17 2015-03-19 Path Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
EP3840770A1 (de) * 2018-08-23 2021-06-30 GlaxoSmithKline Biologicals SA Immunogene proteine und zusammensetzungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
US5556755A (en) * 1993-09-29 1996-09-17 The Research Foundation Of State University Of New York Method for detecting Branhamella catarrhalis
WO1996033276A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025170D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025998D0 (en) * 2000-10-24 2000-12-13 Smithkline Beecham Biolog Novel compounds
WO2002088361A2 (en) * 2001-04-30 2002-11-07 Glaxosmithkline Biologicals S.A. Haemophilus influenzae antigens

Also Published As

Publication number Publication date
AU2001295599A1 (en) 2002-04-22
CY1108280T1 (el) 2014-02-12
WO2002030971A2 (en) 2002-04-18
DK1326982T3 (da) 2008-09-29
US7838003B2 (en) 2010-11-23
US20110129475A1 (en) 2011-06-02
EP1847609A1 (de) 2007-10-24
GB0025171D0 (en) 2000-11-29
ES2305111T3 (es) 2008-11-01
DE60134253D1 (de) 2008-07-10
PT1326982E (pt) 2008-08-13
CA2424938A1 (en) 2002-04-18
EP1326982B1 (de) 2008-05-28
WO2002030971A3 (en) 2002-11-07
EP1326982A2 (de) 2003-07-16
US20040022803A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
ATE311457T1 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
DE69928925D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
GB9820003D0 (en) Novel compounds
DE60043499D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
GB9809683D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
GB9812163D0 (en) Novel compounds
GB0025170D0 (en) Novel compounds
GB9918208D0 (en) Novel compounds
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds
ATE274582T1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
WO2003010195A3 (en) Novel compounds
GB9918206D0 (en) Novel compounds
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
GB9918281D0 (en) Novel compounds
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1326982

Country of ref document: EP